NanoViricides Inc. (NNVC)

[drkazmd65]

Well - If what that last set of PRs/updates us accurate - and the NV-387 candidate drug may also be effective against other viruses with the same attachment points - they could just use the existing Phase 1a/b data for COVID treatment and plan a Phase II against something else. The Phase I studies are primarily focused on safety and dosage testing. Those safety/dosage data should also be applicable to treating other viruses.

That last PR back right after Thanksgiving specifically mentioned RSV as something that could be aimed at as well as other coronaviruses. There's definitely a market there and another significant medical problem that doesn't appear to be going away even if COVID is more under control than it used to be.